Medication info
Esomeprazole Magnesium Trihydrate 40 mg Tablets

Esomeprazole Magnesium Trihydrate 40 mg Tablets

Prescription medicationTablet
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Pink round film-coated tablets
Packaging
28 tablets (14 tablets/PTPX2)
Approval status
Active

MFDS item code 201403573 · Approved 2014.07.31 · Insurance code 644913770

Summary

Main use
Treatment of reflux and Zollinger–Ellison syndrome, ulcers (including eradication therapy and prevention of rebleeding), and gastrointestinal symptoms caused by anti-inflammatory drugs
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of GERD without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurrent symptoms should be controlled by administering 20 mg once daily. · In adults, 20 mg once daily may be taken as needed. As-needed use is not recommended for ongoing symptom control in patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Concomitant antibiotic therapy for eradication of Helicobacter pylori Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials extending beyond 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with the use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with the use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue for as long as clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided and taken twice daily. 6) Maintenance therapy following intravenous induction to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience with administration to patients with severe renal failure. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Elderly patients: No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older - Gastroesophageal reflux disease (GERD), treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Adolescents aged 12 years and older - Gastroesophageal reflux disease (GERD), symptomatic treatment of GERD without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years and older - Gastroesophageal reflux disease (GERD), symptomatic treatment of GERD without esophagitis: Once symptoms have resolved, subsequent recurrent symptoms should be controlled by administering 20 mg once daily. Adolescents aged 12 years and older - Gastroesophageal reflux disease (GERD), symptomatic treatment of GERD without esophagitis: In adults, 20 mg once daily may be taken as needed. As-needed use is not recommended for ongoing symptom control in patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of reflux and Zollinger–Ellison syndrome, ulcers (including eradication therapy and prevention of rebleeding), and gastrointestinal symptoms caused by anti-inflammatory drugs

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, particularly erosive reflux esophagitis, and for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It also helps relieve symptoms in patients with gastroesophageal reflux disease without esophagitis. It is included in combination therapy with antibiotics for eradication of Helicobacter pylori and is effective for the treatment and prevention of recurrence in patients with duodenal or peptic ulcers confirmed to be positive for Helicobacter pylori. The medication is also used to treat upper gastrointestinal symptoms from non-steroidal anti-inflammatory drug administration, as well as for the treatment and prevention of gastric ulcers in patients who require such medications. It is utilized in the treatment of Zollinger-Ellison syndrome and as maintenance therapy to prevent rebleeding from gastric or duodenal ulcers induced by intravenous administration. This drug plays a significant role in alleviating various gastrointestinal diseases and associated symptoms.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of GERD without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurrent symptoms should be controlled by administering 20 mg once daily. · In adults, 20 mg once daily may be taken as needed. As-needed use is not recommended for ongoing symptom control in patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Concomitant antibiotic therapy for eradication of Helicobacter pylori Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials extending beyond 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with the use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with the use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue for as long as clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided and taken twice daily. 6) Maintenance therapy following intravenous induction to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience with administration to patients with severe renal failure. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Elderly patients: No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older - Gastroesophageal reflux disease (GERD), treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Adolescents aged 12 years and older - Gastroesophageal reflux disease (GERD), symptomatic treatment of GERD without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years and older - Gastroesophageal reflux disease (GERD), symptomatic treatment of GERD without esophagitis: Once symptoms have resolved, subsequent recurrent symptoms should be controlled by administering 20 mg once daily. Adolescents aged 12 years and older - Gastroesophageal reflux disease (GERD), symptomatic treatment of GERD without esophagitis: In adults, 20 mg once daily may be taken as needed. As-needed use is not recommended for ongoing symptom control in patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This drug should not be administered to certain patients. Do not take this medication if you are allergic to this drug or its components, or have a history of hypersensitivity to benzimidazole derivatives. Caution is also needed when co-administering with penicillin or macrolide antibiotics for the eradication of Helicobacter pylori, if you are allergic to those antibiotics. Patients taking certain medications that affect the heart, those with a history of myocardial infarction, and breastfeeding women should avoid this medication. Various adverse reactions may occur while taking this medication. For example, decreased blood cell counts, allergic reactions, electrolyte imbalances such as hyponatremia or hypomagnesemia, headaches, dizziness, abdominal pain, diarrhea, liver function abnormalities, and skin rashes have been reported. In particular, long-term use may lead to hypomagnesemia, thus regular blood tests are necessary. This medication suppresses gastric acid secretion, which may increase the risk of gastrointestinal bacterial infections during long-term use. Additionally, prolonged use may increase the risk of osteoporotic fractures, so patients at risk of fractures should be cautious. This drug has numerous drug interactions, and those taking other medications should consult with a physician or pharmacist. Special caution is needed when taken with anticoagulants, anticonvulsants, certain antidepressants, antiviral agents, and antibiotics, as side effects may occur due to changes in drug concentration. During pregnancy, data on the safety of this medication is limited, and pregnant women should take it cautiously under a physician's guidance. Nursing women are advised to avoid taking this medication as it is uncertain whether it is passed into breast milk. In case of overdose, there are no specific antidotes, and appropriate symptomatic treatment should be administered, as this medication is not removed by dialysis. Finally, this medication should be kept out of reach of children, and it is important not to transfer it to other containers to maintain quality.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, sensory disturbance, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Liell syndrome, acute generalized pustular psoriasis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, worsening of depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorder, tremor, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, shortness of breath, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal pruritus, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, altered taste, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Avoid places that are too hot or too cold, and store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

28 tablets (14 tablets/PTPX2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.